Review article · 18 Jul 2016
ArticlePublished 22 Jul 2016
Bioengineering stents with proactive biocompatibility
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Percutaneous coronary intervention has revolutionized the treatment of coronary artery disease. Successive improvements in implantation techniques, stent materials and design, combined with dual antiplatelet therapy have improved stent safety. However, optimal biocompatibility and long-term effectiveness in the absence of pharmaceutical intervention remains elusive. Drug-eluting stents, introduced to combat in-stent restenosis was found to impair endothelial regeneration, increasing thrombotic risk. Innovations in polymer technology and new stent designs have improved, but not solved, these issues. Despite the drawbacks of drug elution it remains a key component of stent platforms, leaving the need for a truly biocompatible platform with lasting clinical efficacy and safety unmet. This review will examine current stent designs and explore proactive approaches to enhance stent biocompatibility.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 30 Dec 2024
The Future of Treating Coronary Artery Disease: Drug-eluting Stents and Advancements Ahead
Commentary · 29 Nov 2024
Drug-Eluting Stents in Coronary Chronic Total Occlusion Interventions
Research article · 2018
Clinical Outcomes of Rotational Atherectomy in Calcified Coronary Artery Lesions in Drug-Eluting Stent Era: A Single Centre Experience
Case report · 6 Jan 2017
Giant Coronary Artery Aneurysm after Drug-Eluting Stent (DES) Implantation: Therapeutic Challenges and Management
More from this journal
The newest in Interventional Cardiology.
Article · 27 May 2026
Commentary on Stent-Induced Coronary Stenosis in a Previously Noncritical Segment Following PCI: A Case Report
Article · 24 Mar 2026
Redo arteriovenous fistula in end stage kidney disease: Risk factors and outcomes in Taiz – Yemen
Article · 23 Feb 2026
The Silent Giant : Incidental Discovery of a Large Left Atrial Myxoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Y Yu”
- BylineArticles whose byline prints “SG Wise”
- BylineArticles whose byline prints “DS Celermajer”
- BylineArticles whose byline prints “MMM Bilek & MKC Ng”
